期刊文献+

新型青蒿素衍生物SM1044诱导Kasumi-1细胞凋亡及机制的研究 被引量:6

A New Artemisinin Derivative SM1044 Induces Apoptosis of Kasumi-1 Cells and Its Mechanism
下载PDF
导出
摘要 本研究探讨新型水溶性青蒿素衍生物SM1044对人急性髓系白血病M2b细胞株Kasumi-1的诱导凋亡作用及其机制。应用四甲基偶氮唑蓝(MTT)还原法观察SM1044对细胞生长的抑制作用;Annexin-Ⅴ/PI双标记流式细胞术、PI单标记流式细胞术分别检测细胞凋亡和细胞周期;Western blot检测加药处理后Kasumi-1细胞凋亡相关蛋白Caspase 3、PARP以及融合蛋白AML1-ETO的变化。结果显示:青蒿素衍生物SM1044可抑制Kasumi-1细胞的增殖,其抑制作用呈时间和剂量依赖性;1μmol/L SM1044作用24小时,生长抑制率达到50%,48小时的IC50值为0.17±0.067μmol/L;SM1044通过Caspase依赖的途径诱导Kasumi-1细胞凋亡,细胞凋亡率随药物浓度的增加而增加。细胞周期测定显示,SM1044阻滞细胞周期于G0/G1期,5μmol/LSM1044作用24小时使G0/G1期细胞由(58.33±4.46)%上升为(71.75±2.24)%;Western blot测定显示SM1044促使凋亡相关蛋白cCaspase 3(cleaved Caspase 3)、cPARP(cleaved PARP)表达水平增加,同时融合蛋白AML1-ETO表达降低。结论 :SM1044可有效抑制Kasumi-1细胞增殖,诱导细胞凋亡,该过程与cCaspase 3、cPARP蛋白的表达上调有关。SM1044还能阻滞细胞周期,将Kasumi-1细胞阻滞在G0/G1期;同时SM1044能明显引起融合蛋白AML1-ETO的表达降低,可作为SM1044作用的胞内靶点。 The aim of this study was to investigate the apoptosis-inducing effect of artemisinin derivative SM1044 on Kasumi-1 cells and its possible mechanism. Kasumi-1 cells were treated with different concentrations of SM1044, the cell viability was evaluated by MTT assay. Cell apoptosis and cell cycle progression were assessed by using flow cytometry with Annexin-V/PI double staining and flow cytometry with PI staining respectively. The expression of apoptosis-related proteins caspase 3, PARP and the fusion protein AML1-ETO were detected by Western blot. The results indicated that SM1044 inhibited cell growth of Kasumi-1 cells in time- and dose-dependent manners. After exposure of Kasumi-1 cells to 1 ixmol/L SM1044 for 24 hours, the cell viability was decreased to 50%. IC50 of SM1044 to Kasumi-1 cells at 48 hours was 0.17 ±0. 067 μmol/L. SM1044 induced cell apoptosis in a caspase-dependent manner, and the apoptotic rate of Kasumi-1 cells increased as SM1044 concentration increased. Flow cytometry with PI staining revealed that SM1044 induced cell cycle arrest, and the proportion of ceils in G0/G1 phase increased from 58.33 ± 4.46% to 71.75 ± 2.24% after exposure to 5 μmol/L SM1044 for 24 hours. Western blot showed that SM1044 increased the expression of apoptosis-related proteins cPARP and cleaved caspase 3 and also degraded the AML1-ETO fusion protein. It is concluded that SM1044 can inhibit the proliferation of Kasumi-1 cells, induce cell apoptosis which may be releted to the increased level of cleaved PARP and cleaved caspase 3. SM1044 can also induce cell arrest in G0/G1 phase. As the fusion protein AML1-ETO degrades obviously, it can be the potential target of SM1044 in Kasumi-1 cells.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第3期607-611,共5页 Journal of Experimental Hematology
基金 国家自然科学基金面上项目(编号30871106) 973国家重大基础研究发展计划(编号2010CB529203)
关键词 青蒿素衍生物 SM1044 KASUMI-1细胞 AML1-ETO融合蛋白 细胞凋亡 Artemisinin derivative SM1044 Kasumi-1 ceil AML1-ETO fusion gene cell apoptsis
  • 相关文献

参考文献17

  • 1Peterson LF, Zhang DE. The 8 ;21 translocation in leukemogenesis. Oncogene, 2004 ; 23 (24) : 4255 - 4262.
  • 2Wang J, Hoshino T, Redner RL, et al. ETO, fusion partner in t ( 8 ; 21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/ HDAC1 complex. Proc Natl Acad Sci USA, 1998; 95(18): 10860-10865.
  • 3钱海洪,胡义德.青蒿素类药物抗肿瘤作用机制的研究进展[J].中华肿瘤防治杂志,2006,13(11):867-869. 被引量:19
  • 4Efferth T. Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. Drug Resist Updat, 2005 ; 8 ( 1 - 2 ) : 85 - 97.
  • 5van Agtmael MA, Eggelte TA, van Boxtel CJ. Artemisinin drugs in the treatment malaria: from medicinal herb to registered medication. Trends Pharmacol Sci, 1999 ; 20 ( 5 ) : 199 - 205.
  • 6Zhou HI, Zhang JL, Li A, et al. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits mufine Lewis lung carcinoma cell line growth in vitro. Cancer Chemother Phannacol, 2010; 66( 1 ) : 21 -29.
  • 7Chen H, Sun B, Wang S, et al. Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB. J Cancer Res Clin Oncol, 2010; 136(6) : 897 -903.
  • 8Willoughby JA Sr, Sundar SN, Cheung M, et al. Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Spl interactions with the cyclin-dependent kinasc-4 (CDK4) promoter and inhibiting CDK4 gene expression. J Biol Chem, 2009; 284 (4) : 2203 - 2213.
  • 9Zhou HJ, Wang Z, Li A. Dihydroartemisinin induces apoptosis in human leukemia cells HL-60 via downregulation of transferrin receptor expression. Anticancer Drugs, 2008; 19(3) : 247 -255.
  • 10DellEva R, Pfeffer U, Vene R, et al. Inhibition of angiogenesis in vivo and growth of Kaposis sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol, 2004 ; 68 (12) : 2359 - 2366.

二级参考文献25

  • 1Johann-Liang R,Albrecht R.Safety evaluations of drugs contai ning artemisinin derivatives for the treatment of malaria[J].Clin Infect Dis,2003,36(12),1627-1628.
  • 2Ribeiro I R,Olliaro P.Safety of artemisinin and its derivatives.A review of published and unpublished clinical trials[J].Med Trop,1998,58(3 Suppl):50-53.
  • 3Efferth T,Sauerbrey A,Olbrich A,et al.Molecular modes of action of artesunate in tumor cell lines[J].Mol Pharmacol,2003,64(2):382-394.
  • 4van Agtmael M A,Eggelte T A,van Boxtel C J.Artemisinin drugs inthe treatment of malaria:from medicinal herb to registered medication[J].Trends Pharmacol Sci,1999,20(5):199-205.
  • 5Shterman N,Kupfer B,Moroz C.Comparison of transferrin receptors,iron content and isoferritin profile in normal and malignant hu man breast cell lines[J].Pathobiology,1991,59(1):19-25.
  • 6Reizenstein P.Iron,free radicals and cancer[J].Med Oncol Tumor Pharmacother,1991,8(4):229-233.
  • 7Raaf H N,Jacobsen D W,Savon S,et al.Serum transferrin receptor level is not altered in invasive adenocarcinoma of the breast[J].Am J Clin Pathol,1993,99(3):232-237.
  • 8Henry Lai,Narendra P.Singh Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin[J].Cancer Letters,1995,1(91):41 -46.
  • 9Singh N P,Lai H.Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells[J].Life Sci,2001,70(1):49-56.
  • 10Efferth T,Benakis A,Romero M R.Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron[J].Free Radic Biol Med,2004,7 (37):998-1009.

共引文献69

同被引文献75

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部